Gut-Brain-Axis Therapeutics Inc. — Form D
Gut-Brain-Axis Therapeutics Inc. of TEMPE, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-10. The offering totals $8.0M, of which $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-10
- Form: D
- Accession: 0001996678-23-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $8.0M
- Amount sold: $1.4M
- Remaining: $6.6M
- Investors: 23
- Date of first sale: 2023-09-25
- Revenue range: Decline to Disclose
- SEC file number: 021-494244
Issuer
- Name: Gut-Brain-Axis Therapeutics Inc.
- CIK: 0001996678
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1340 E VINEDO LANE, TEMPE, AZ, 85284
- Phone: (480) 818-0741
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| James B Adams | Director | Tempe, AZ |
| Alexander B Khorus | Director | Tempe, AZ |
| Rosa J Krajalnik-Brown | Director | Tempe, AZ |
| Michael J Sadowsky | Director | Tempe, AZ |
| James B Adams | Executive Officer | Tempe, AZ |
| Alexander B Khoruts | Director | Tempe, AZ |
| Rosa B Krajmalnik-Brown | Director | Tempe, AZ |
Other filings by this issuer (1)
More